Exenatide · 2023-12-29
ClinicalTrials.gov record NCT01524705
Completed at observation.
Open attributed record →ClinicalTrials.gov registry-update year
2023 peptide clinical trials
46 selected ClinicalTrials.gov records carrying a 2023 registry-update date. This is selective historical coverage, not a complete trial inventory or an assessment of study quality.
Registry records
46 selected records.
Peptide profiles
13 connected profiles.
Completed at observation
45 retained records.
Attributed registry records
Selected records
Liraglutide · 2023-12-04
ClinicalTrials.gov record NCT03795701
Completed at observation.
Open attributed record →Octreotide · 2023-11-27
ClinicalTrials.gov record NCT02381249
Completed at observation.
Open attributed record →Octreotide · 2023-11-27
ClinicalTrials.gov record NCT02385617
Completed at observation.
Open attributed record →Leuprolide · 2023-11-13
ClinicalTrials.gov record NCT00541047
Completed at observation.
Open attributed record →Leuprolide · 2023-10-30
ClinicalTrials.gov record NCT06106932
Completed at observation.
Open attributed record →Pramlintide · 2023-10-25
ClinicalTrials.gov record NCT05199714
Completed at observation.
Open attributed record →Afamelanotide · 2023-09-22
ClinicalTrials.gov record NCT04525157
Completed at observation.
Open attributed record →Setmelanotide · 2023-09-21
ClinicalTrials.gov record NCT02896192
Completed at observation.
Open attributed record →Liraglutide · 2023-09-08
ClinicalTrials.gov record NCT03737240
Completed at observation.
Open attributed record →Semaglutide · 2023-09-08
ClinicalTrials.gov record NCT04263415
Completed at observation.
Open attributed record →Leuprolide · 2023-08-18
ClinicalTrials.gov record NCT00002889
Completed at observation.
Open attributed record →Teriparatide · 2023-08-02
ClinicalTrials.gov record NCT04026256
Completed at observation.
Open attributed record →Liraglutide · 2023-07-27
ClinicalTrials.gov record NCT03936049
Completed at observation.
Open attributed record →Teriparatide · 2023-07-27
ClinicalTrials.gov record NCT04879420
Completed at observation.
Open attributed record →Leuprolide · 2023-07-27
ClinicalTrials.gov record NCT04897958
Completed at observation.
Open attributed record →Exenatide · 2023-07-24
ClinicalTrials.gov record NCT03331289
Completed at observation.
Open attributed record →Liraglutide · 2023-07-18
ClinicalTrials.gov record NCT03374956
Completed at observation.
Open attributed record →Liraglutide · 2023-07-06
ClinicalTrials.gov record NCT02527200
Completed at observation.
Open attributed record →Octreotide · 2023-07-05
ClinicalTrials.gov record NCT00427349
Completed at observation.
Open attributed record →Pramlintide · 2023-06-29
ClinicalTrials.gov record NCT01841359
Completed at observation.
Open attributed record →Lanreotide · 2023-06-29
ClinicalTrials.gov record NCT03043664
Completed at observation.
Open attributed record →Octreotide · 2023-06-18
ClinicalTrials.gov record NCT00003057
Completed at observation.
Open attributed record →Octreotide · 2023-06-15
ClinicalTrials.gov record NCT00003283
Completed at observation.
Open attributed record →Liraglutide · 2023-06-07
ClinicalTrials.gov record NCT04605861
Completed at observation.
Open attributed record →Octreotide · 2023-05-25
ClinicalTrials.gov record NCT02333565
Completed at observation.
Open attributed record →Octreotide · 2023-05-24
ClinicalTrials.gov record NCT02384122
Completed at observation.
Open attributed record →Setmelanotide · 2023-05-23
ClinicalTrials.gov record NCT03287960
Completed at observation.
Open attributed record →Teriparatide · 2023-05-12
ClinicalTrials.gov record NCT03072147
Completed at observation.
Open attributed record →Liraglutide · 2023-05-11
ClinicalTrials.gov record NCT01779362
Completed at observation.
Open attributed record →Glucagon · 2023-05-11
ClinicalTrials.gov record NCT04859322
Completed at observation.
Open attributed record →Leuprolide · 2023-05-10
ClinicalTrials.gov record NCT02058706
Completed at observation.
Open attributed record →Exenatide · 2023-04-26
ClinicalTrials.gov record NCT01416649
Completed at observation.
Open attributed record →Afamelanotide · 2023-04-11
ClinicalTrials.gov record NCT04962503
Completed at observation.
Open attributed record →Abaloparatide · 2023-04-07
ClinicalTrials.gov record NCT03512262
Completed at observation.
Open attributed record →Tirzepatide · 2023-03-27
ClinicalTrials.gov record NCT04172987
Completed at observation.
Open attributed record →Tirzepatide · 2023-03-24
ClinicalTrials.gov record NCT03940742
Completed at observation.
Open attributed record →Leuprolide · 2023-03-02
ClinicalTrials.gov record NCT00001259
Completed at observation.
Open attributed record →Leuprolide · 2023-02-16
ClinicalTrials.gov record NCT03043807
Completed at observation.
Open attributed record →Abaloparatide · 2023-02-15
ClinicalTrials.gov record NCT04064411
Completed at observation.
Open attributed record →Teriparatide · 2023-02-13
ClinicalTrials.gov record NCT04589819
Current at observation.
Open attributed record →Afamelanotide · 2023-02-09
ClinicalTrials.gov record NCT05368857
Completed at observation.
Open attributed record →Teriparatide · 2023-01-26
ClinicalTrials.gov record NCT03472846
Completed at observation.
Open attributed record →Abaloparatide · 2023-01-23
ClinicalTrials.gov record NCT03746041
Completed at observation.
Open attributed record →Liraglutide · 2023-01-20
ClinicalTrials.gov record NCT02967757
Completed at observation.
Open attributed record →Teriparatide · 2023-01-05
ClinicalTrials.gov record NCT02440581
Completed at observation.
Open attributed record →